The report provides a detailed analysis essential for establishing an Ixabepilone production plant. It encompasses all critical aspects necessary for Ixabepilone production, including the cost of Ixabepilone production, Ixabepilone plant cost, Ixabepilone production costs, and the overall Ixabepilone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Ixabepilone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Ixabepilone is an anticancer medicine with a significant role in healthcare settings. It is mainly used in the treatment of advanced breast cancer, especially when the disease no longer responds to commonly used chemotherapy drugs like anthracyclines and taxanes.
It works by targeting the microtubules inside cancer cells, helping slow their growth and eventually stopping them from dividing. It can be given alone or in combination with other medicines to improve treatment outcomes in difficult cases. Moreover, it offers an additional option for patients with aggressive or metastatic breast cancer who need therapies that act through a different pathway to help control the disease.
The market for Ixabepilone is primarily driven by its application as an important chemotherapy medicine for treating advanced or metastatic breast cancer, which fuels its demand in the medical sector. Its application as an anticancer medicine for patients who no longer respond to commonly used chemotherapy drugs also drives demand in the medical and pharmaceutical industries.
Its involvement in managing drug-resistant tumours also strengthens its demand in the oncology sector and helps drive its market growth. Growing awareness of recurrent and hard-to-treat cancers, along with wider access to specialised cancer care, further increases its usage in hospitals and treatment centres.
Moreover, industrial Ixabepilone procurement is shaped by factors such as the cost and availability of specialised raw materials, strict regulatory standards, and adherence to environmental and safety guidelines during production. Advancements in formulation methods, reliable supplier networks, sustainability efforts, and efficient distribution systems also play a major role in influencing procurement decisions for Ixabepilone.
Raw Material for Ixabepilone Production
According to the Ixabepilone production plant project report, the major raw materials for Ixabepilone production includes Epothilone B.
Production Process of Ixabepilone
The extensive Ixabepilone production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of ixabepilone starts with the treatment of epothilone B with sodium azide, tetrabutylammonium chloride, ammonium chloride, trimethylphosphine, and a palladium catalyst in chloroform to form an open-chain amino acid. This step opens the lactone ring and forms the required amine intermediate. Then, the material is taken forward to a controlled cyclisation step, where it is reacted with potassium carbonate, HOBt, and EDCI to form the lactam ring of ixabepilone. After cyclisation is complete, the crude product is isolated and purified through recrystallisation from a cyclohexane–ethyl acetate mixture to obtain ixabepilone in its finished form.
Ixabepilone is a semi-synthetic anticancer agent that appears as a white to off-white solid with little to no smell. Its molecular formula is C27H42N2O5S, and its molar mass is 506.7 g/mol. The density of the solid is around 1.122 g/cm³. It decomposes when heated above 160 degree Celsius, so the compound has no reliable melting point, boiling point, or flash point under normal conditions. Ixabepilone is only slightly soluble in organic solvents such as chloroform or methanol, and it is essentially insoluble in water. The compound is cytotoxic, so handling the raw material requires utmost care. The compound, upon contact or ingestion, can pose serious health risks, and protective equipment should be used when handling it in solid form.